PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $54,684 | -68.3% | 17,697 | -56.6% | 0.00% | – |
| Q4 2022 | $172,660 | +439.6% | 40,818 | +268.5% | 0.00% | – |
| Q2 2022 | $32,000 | -70.9% | 11,076 | -1.6% | 0.00% | – |
| Q1 2021 | $110,000 | -91.1% | 11,257 | -90.7% | 0.00% | – |
| Q4 2020 | $1,237,000 | +13.2% | 120,621 | +11.4% | 0.00% | – |
| Q3 2020 | $1,093,000 | +300.4% | 108,246 | +313.4% | 0.00% | – |
| Q2 2020 | $273,000 | +150.5% | 26,183 | +103.6% | 0.00% | – |
| Q1 2020 | $109,000 | -89.8% | 12,863 | -89.5% | 0.00% | -100.0% |
| Q4 2019 | $1,068,000 | +228.6% | 122,066 | +304.9% | 0.00% | 0.0% |
| Q3 2019 | $325,000 | -83.6% | 30,150 | -41.0% | 0.00% | -66.7% |
| Q1 2019 | $1,981,000 | +248.8% | 51,084 | +83.1% | 0.00% | +200.0% |
| Q4 2018 | $568,000 | -26.9% | 27,896 | +64.6% | 0.00% | -50.0% |
| Q3 2018 | $777,000 | -67.7% | 16,944 | -58.4% | 0.00% | -66.7% |
| Q2 2018 | $2,409,000 | +53.3% | 40,717 | +156.1% | 0.01% | +20.0% |
| Q4 2017 | $1,571,000 | -56.4% | 15,901 | -47.2% | 0.01% | -58.3% |
| Q3 2017 | $3,603,000 | -44.1% | 30,090 | -59.2% | 0.01% | -47.8% |
| Q2 2017 | $6,451,000 | +352.1% | 73,804 | +246.8% | 0.02% | +228.6% |
| Q3 2016 | $1,427,000 | +23.0% | 21,279 | +43.8% | 0.01% | 0.0% |
| Q4 2015 | $1,160,000 | -59.9% | 14,800 | -40.3% | 0.01% | -63.2% |
| Q2 2015 | $2,894,000 | +163.6% | 24,785 | +327.1% | 0.02% | +137.5% |
| Q4 2014 | $1,098,000 | +10.5% | 5,803 | +39.3% | 0.01% | -20.0% |
| Q3 2014 | $994,000 | +392.1% | 4,167 | +114.5% | 0.01% | +400.0% |
| Q1 2014 | $202,000 | – | 1,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |